Provided by Tiger Trade Technology Pte. Ltd.

Haleon

10.88
-0.1000-0.91%
Post-market: 10.880.00000.00%18:52 EST
Volume:8.29M
Turnover:89.86M
Market Cap:48.45B
PE:25.93
High:10.96
Open:10.92
Low:10.78
Close:10.98
52wk High:11.42
52wk Low:8.71
Shares:4.45B
Float Shares:4.45B
Volume Ratio:1.07
T/O Rate:0.19%
Dividend:0.18
Dividend Rate:1.68%
EPS(TTM):0.4196
EPS(LYR):0.3931
ROE:9.38%
ROA:4.61%
PB:2.22
PE(LYR):27.68

Loading ...

Company Profile

Company Name:
Haleon
Exchange:
NYSE
Establishment Date:
1715
Employees:
24561
Office Location:
The Heights,Building 5, First Floor,Weybridge,Surrey,United Kingdom
Zip Code:
KT13 0NY
Fax:
- -
Introduction:
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.